Function of a membrane-localized nuclear receptor
膜定位核受体的功能
基本信息
- 批准号:7050020
- 负责人:
- 金额:$ 29.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-05 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegansRNA interferencebiological signal transductionbiotechnologycell membranedevelopmental geneticsfunctional /structural genomicsgene mutationhelminth geneticshormone receptorhormone regulation /control mechanismhormone sensitivity /resistancelarvanuclear receptorspheromoneprotein localizationprotein protein interactionprotein structure function
项目摘要
DESCRIPTION (provided by applicant): The long-term goals are to understand how a nuclear hormone receptor (NHR) is directed to the plasma membrane in response to a signal and how it might function in a non-nuclear signal transduction system. While the classical view of steroid signaling holds that these hormones bind intracellular receptors that act as ligand-activated transcription factors, extensive evidence indicates that steroids can also act by a non-genomic mechanism at the cell surface. We have identified a C. elegans NHR, DPR-1, that may act through such a membrane-based signaling system, providing the first genetic system for dissecting a membrane-based NHR signaling system. In the presence of a small lipophilic molecule (dauer pheromone or "daumone") DPR-1 moves from the cytoplasm to the plasma membrane. Daumone triggers an alternative, developmental arrested state, the dauer larva. A deletion mutation of the dpr-1 gene attenuates responsiveness to dauer pheromone and accelerates exit from the dauer state, and overexpression of DPR- 1 triggers inappropriate dauer development and inhibits exit from the dauer state. The dauer regulatory pathway is required for relocalization of DPR-1 to the membrane. The proposed studies will test the hypothesis that DPR-1 regulates dauer formation through a plasma membrane signal transduction system. Aim 1 will investigate parameters that influence relocalization of DPR-1 in response to dauer pheromone, analyze the essential function of dpr-1, test for redundant partners of DPR-1, and assess the relationship between DPR-1 and the dauer pathway. Aim 2 will identify structural elements and components required for DPR-1 signaling and membrane association, test its signaling function when targeted to the membrane and nucleus, examine the basis for a membrane-tenacious form of DPR-1 in dauer larvae, and investigate physical interactions between DPR-1 and other proteins. Aim 3 will examine whether DPR-1 responds to dauer pheromone in heterologous cells and whether DPR-1 relatives and the dauer-regulating NHR, DAF- 12, associate with the membrane under dauer-favoring conditions. Aim 4 will initiate RNAi screens to identify components responsible for relocalization of DPR-1 and genes with which it collaborates. The elucidation of novel pathways through which NHRs function may advance our understanding of many developmental defects and the hormonal influences on normal human physiology and a variety of human pathologies.
描述(由申请人提供):长期目标是了解核激素受体(NHR)如何响应信号定向至质膜,以及它如何在非核信号转导系统中发挥作用。虽然类固醇信号传导的经典观点认为这些激素结合作为配体激活的转录因子的细胞内受体,但大量证据表明类固醇也可以通过细胞表面的非基因组机制起作用。我们已经确定了一个C。线虫NHR,DPR-1,其可以通过这种基于膜的信号系统起作用,提供了用于解剖基于膜的NHR信号系统的第一个遗传系统。在存在小的亲脂性分子(道厄信息素或“道蒙”)的情况下,DPR-1从细胞质移动到质膜。杜蒙引发了另一种发育停滞状态,即幼虫。dpr-1基因的缺失突变减弱了对dauer信息素的反应性并加速退出dauer状态,并且DPR- 1的过表达触发了不适当的dauer发育并抑制退出dauer状态。DPR-1在细胞膜上的再定位需要dauer调节通路。本研究将验证DPR-1通过质膜信号转导系统调节dauer形成的假设。目的1研究影响DPR-1在dauer信息素作用下重定位的参数,分析DPR-1的基本功能,检测DPR-1的冗余配偶体,并评估DPR-1与dauer途径之间的关系。目标2将确定DPR-1信号传导和膜缔合所需的结构元件和组件,测试其针对膜和细胞核的信号传导功能,检查DPR-1在Dauer幼虫中的膜粘性形式的基础,并研究DPR-1与其他蛋白质之间的物理相互作用。目的3将检查DPR-1是否响应于异源细胞中的dauer信息素,以及DPR-1亲属和dauer调节NHR,NHR- 12是否在dauer有利条件下与膜结合。Aim 4将启动RNAi筛选,以确定负责DPR-1重新定位的组件以及与其合作的基因。阐明NHRs功能的新途径可能会促进我们对许多发育缺陷和激素对正常人类生理和各种人类病理的影响的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel H. Rothman其他文献
Joel H. Rothman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel H. Rothman', 18)}}的其他基金
A model for elimination of defective mitochondrial genomes
消除有缺陷的线粒体基因组的模型
- 批准号:
10043796 - 财政年份:2020
- 资助金额:
$ 29.03万 - 项目类别:
MARC at the University of California Santa Barbara
加州大学圣塔芭芭拉分校 MARC
- 批准号:
10625331 - 财政年份:2020
- 资助金额:
$ 29.03万 - 项目类别:
A model for elimination of defective mitochondrial genomes
消除有缺陷的线粒体基因组的模型
- 批准号:
10266765 - 财政年份:2020
- 资助金额:
$ 29.03万 - 项目类别:
Developmental reprogramming and transorganogenesis
发育重编程和跨器官发生
- 批准号:
10588050 - 财政年份:2015
- 资助金额:
$ 29.03万 - 项目类别:
UC Santa Barbara MARC Program: Bridges to Biomedical Research Careers
加州大学圣巴巴拉分校 MARC 项目:通向生物医学研究职业的桥梁
- 批准号:
8856392 - 财政年份:2015
- 资助金额:
$ 29.03万 - 项目类别:
Developmental reprogramming and transorganogenesis
发育重编程和跨器官发生
- 批准号:
8888152 - 财政年份:2015
- 资助金额:
$ 29.03万 - 项目类别:
Plasticity in an embryonic gene regulatory network
胚胎基因调控网络的可塑性
- 批准号:
9020247 - 财政年份:2015
- 资助金额:
$ 29.03万 - 项目类别:
Plasticity in an embryonic gene regulatory network
胚胎基因调控网络的可塑性
- 批准号:
10299492 - 财政年份:2015
- 资助金额:
$ 29.03万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 29.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 29.03万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 29.03万 - 项目类别:
Continuing Grant














{{item.name}}会员




